Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs

Lithium enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells

(2013) Yan Lan et al.   BIOMETALS

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Annual number of lung cancer deaths potentially avertable by screening in the United States

(2013) Jiemin Ma et al.   CANCER

Let-7c Governs the Acquisition of Chemo- or Radioresistance and Epithelial-to-Mesenchymal Transition Phenotypes in Docetaxel-Resistant Lung Adenocarcinoma

(2013) Shi-Yun Cui et al.   MOLECULAR CANCER RESEARCH

Genes Associated with Epithelial-Mesenchymal Transition: Possible Therapeutic Targets in Ductal Pancreatic Adenocarcinoma?

(2012) Hubert G. Hotz et al.   Anti-Cancer Agents in Medicinal Chemistry

Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy

(2012) Toshio Kubo et al.   CANCER SCIENCE

Selective sensitization of tumors to chemotherapy by marine-derived lipids: A review

(2012) Nawale Hajjaji et al.   CANCER TREATMENT REVIEWS

Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM

(2012) Dejuan Kong et al.   PLoS One

Combination Erlotinib-Cisplatin and Atg3-Mediated Autophagy in Erlotinib Resistant Lung Cancer

(2012) Jasmine G. Lee et al.   PLoS One

Intrinsic caspase-8 activation mediates sensitization of erlotinib-resistant tumor cells to erlotinib/cell-cycle inhibitors combination treatment

(2012) M Orzáez et al.   Cell Death & Disease

Silencing of the SNARE protein NAPA sensitizes cancer cells to cisplatin by inducing ERK1/2 signaling, synoviolin ubiquitination and p53 accumulation

(2011) Zchong-Zcho Wu et al.   BIOCHEMICAL PHARMACOLOGY

SMAC Mimetic (JP1201) Sensitizes Non-Small Cell Lung Cancers to Multiple Chemotherapy Agents in an IAP-Dependent but TNF- -Independent Manner

(2011) R. M. Greer et al.   CANCER RESEARCH

Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells

(2011) A. Ahmad et al.   CANCER RESEARCH

Epithelial-Mesenchymal Transition: Implications in Cancer Progression and Metastasis

(2011) L. R. Gomes et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells

(2011) Bin Bao et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Up-Regulation of Sonic Hedgehog Contributes to TGF-β1-Induced Epithelial to Mesenchymal Transition in NSCLC Cells

(2011) Ma'in Y. Maitah et al.   PLoS One

Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells

(2010) Yoshihiro Takeyama et al.   CANCER LETTERS

miR-200 Inhibits Lung Adenocarcinoma Cell Invasion and Metastasis by Targeting Flt1/VEGFR1

(2010) J. D. Roybal et al.   MOLECULAR CANCER RESEARCH

Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer

(2010) P. Ceppi et al.   MOLECULAR CANCER RESEARCH

Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib

(2009) Yi-He Ling et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Let-7a elevates p21WAF1levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells

(2009) Xiaoyan He et al.   FEBS LETTERS

Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung

(2009) Ludmila Prudkin et al.   MODERN PATHOLOGY

miR-200 Regulates PDGF-D-Mediated Epithelial-Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer Cells

(2009) Dejuan Kong et al.   STEM CELLS